HELIX BIOPHARMA Total Asset vs. Net Asset
| HBP Stock | EUR 1.15 0.00 0.00% |
For HELIX BIOPHARMA profitability analysis, we use financial ratios and fundamental drivers that measure the ability of HELIX BIOPHARMA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well HELIX BIOPHARMA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between HELIX BIOPHARMA's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of HELIX BIOPHARMA over time as well as its relative position and ranking within its peers.
HELIX |
HELIX BIOPHARMA Net Asset vs. Total Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining HELIX BIOPHARMA's current stock value. Our valuation model uses many indicators to compare HELIX BIOPHARMA value to that of its competitors to determine the firm's financial worth. HELIX BIOPHARMA is one of the top stocks in total asset category among its peers. It also is one of the top stocks in net asset category among its peers making up about 1.00 of Net Asset per Total Asset. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HELIX BIOPHARMA's earnings, one of the primary drivers of an investment's value.HELIX Net Asset vs. Total Asset
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
HELIX BIOPHARMA |
| = | 3.73 M |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
HELIX BIOPHARMA |
| = | 3.73 M |
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
HELIX Net Asset Comparison
HELIX BIOPHARMA is currently under evaluation in net asset category among its peers.
HELIX Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on HELIX BIOPHARMA. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of HELIX BIOPHARMA position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the HELIX BIOPHARMA's important profitability drivers and their relationship over time.
Use HELIX BIOPHARMA in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if HELIX BIOPHARMA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HELIX BIOPHARMA will appreciate offsetting losses from the drop in the long position's value.HELIX BIOPHARMA Pair Trading
HELIX BIOPHARMA Pair Trading Analysis
The ability to find closely correlated positions to HELIX BIOPHARMA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HELIX BIOPHARMA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HELIX BIOPHARMA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HELIX BIOPHARMA to buy it.
The correlation of HELIX BIOPHARMA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as HELIX BIOPHARMA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if HELIX BIOPHARMA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for HELIX BIOPHARMA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your HELIX BIOPHARMA position
In addition to having HELIX BIOPHARMA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Chemicals Thematic Idea Now
Chemicals
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Chemicals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for HELIX Stock Analysis
When running HELIX BIOPHARMA's price analysis, check to measure HELIX BIOPHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HELIX BIOPHARMA is operating at the current time. Most of HELIX BIOPHARMA's value examination focuses on studying past and present price action to predict the probability of HELIX BIOPHARMA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HELIX BIOPHARMA's price. Additionally, you may evaluate how the addition of HELIX BIOPHARMA to your portfolios can decrease your overall portfolio volatility.